Streamlined Production of Purine Derivatives Using One-pot Multi-enzymatic Processes for Food and Pharmaceutical Applications

Javier Sara^*
*Correspondence: Javier Sara, Department of Seafood Science, National Kaohsiung Marine University, 142 Haijhuan Road, Nanzih District, Kaohsiung 81143, Taiwan, Email:

Keywords

Food bioprocessing • Leucine • Catalyze

Introduction

Purine derivatives, including caffeine and theobromine, are valuable in the food and pharmaceutical industries for their stimulant and therapeutic effects. Traditional production methods for these compounds often involve multiple steps and harsh chemicals, leading to low yields and environmental concerns. One-pot multi-enzymatic reactions present a more sustainable and efficient alternative for synthesizing purine derivatives. In this article, we explore the principles behind one-pot multi-enzymatic reactions and their application in producing purine derivatives for the food and pharmaceutical sectors. A critical aspect of this process is selecting appropriate substrates that are compatible with all involved enzymes and do not inhibit their activities. The enzymes must also function optimally under consistent conditions of pH, temperature, and ionic strength to ensure effective collaboration and high reaction efficiency. By optimizing these factors, one-pot multi-enzymatic synthesis can offer a streamlined, eco-friendly approach to producing valuable purine derivatives [1,2].

Literature Review

One-pot multi-enzymatic reactions involve the sequential use of multiple enzymes in a single reaction vessel to catalyze a series of reactions. This approach mimics the metabolic pathways found in living organisms, where multiple enzymes work together to convert substrates into products. By carefully selecting the enzymes and optimizing the reaction conditions, researchers can achieve high yields and selectivity in the synthesis of purine derivatives. Purine derivatives are commonly found in foods and beverages such as coffee, tea, and chocolate, where they contribute to the characteristic flavor and aroma. One-pot multi-enzymatic reactions offer a sustainable approach for the production of these compounds, allowing manufacturers to reduce their reliance on chemical synthesis methods. Additionally, this approach can be used to produce novel purine derivatives with unique properties, expanding the range of flavors and textures available to consumers. In the pharmaceutical industry, purine derivatives are used as active pharmaceutical ingredients in drugs for the treatment of various conditions, including asthma, migraines, and heart disease. One-pot multi-enzymatic reactions offer a costeffective and environmentally friendly approach for the production of these APIs, enabling pharmaceutical companies to reduce their carbon footprint and comply with regulatory requirements for sustainable manufacturing practices [3,4]

Discussion

One-pot multi-enzymatic reactions involve the use of several enzymes in a single reaction vessel to facilitate a series of sequential reactions. This method emulates natural metabolic pathways, where multiple enzymes collaborate to convert substrates into desired products. By selecting the appropriate enzymes and optimizing reaction conditions, researchers can achieve high yields and selectivity in synthesizing purine derivatives. Purine derivatives, such as those found in coffee, tea, and chocolate, contribute to the distinct flavors and aromas of these products. One-pot multi-enzymatic reactions provide a sustainable production method for these compounds, reducing the need for chemical synthesis and its associated environmental impact. This approach also allows for the creation of novel purine derivatives with unique properties, potentially offering new flavors and textures for consumers. In the pharmaceutical industry, purine derivatives serve as Active Pharmaceutical Ingredients (APIs) in treatments for conditions like asthma, migraines, and heart disease. Utilizing one-pot multi-enzymatic reactions for API production offers a cost-effective and eco-friendly alternative, helping pharmaceutical companies lower their carbon footprint and meet regulatory standards for sustainable manufacturing practices [5,6].

Conclusion

The application of one-pot multi-enzymatic reactions for producing purine derivatives shows considerable promise for both the food and pharmaceutical industries. Future research could explore broadening the spectrum of purine derivatives that can be synthesized using this technique and optimizing reaction conditions to enhance yields and selectivity. Additionally, advancements in enzyme engineering and bioprocess optimization could improve the commercial viability of this technology for large-scale production. In the food industry, purine derivatives such as Inosine Monophosphate (IMP) and Guanosine Monophosphate (GMP) are valuable flavor enhancers used to enrich the taste of various products like soups, sauces, and snacks. Employing one-pot multi-enzymatic synthesis for these compounds provides a cost-effective and sustainable approach to producing high-purity flavor enhancers, benefiting both the efficiency of production and the quality of the final products.

Acknowledgement

None.

Conflict of Interest

There is no conflict of interest by author.

References

1. Husain, S. R., J. Han, P. Au and K. Shannon, et al. "Gene therapy for cancer: Regulatory considerations for approval." Cancer Gene Ther 22 (2015): 554-563.

   Google Scholar, Crossref, Indexed at

2. Wang, Qiang, Meng Chen, Guoqiang Shan and Pengyu Chen, et al. "Bioaccumulation and biomagnification of emerging bisphenol analogues in aquatic organisms from Taihu Lake, China."Sci Total Environ 598 (2017): 814-820.

   Google Scholar, Crossref, Indexed at

3. Adeyi, Adebola A. and Babafemi A. Babalola. "Bisphenol-A (BPA) in foods commonly consumed in Southwest Nigeria and its human health risk."Sci Rep (2019): 17458.

   Google Scholar, Crossref, Indexed at

4. Clément, Nathalie and Joshua C. Grieger. "Manufacturing of recombinant adeno-associated viral vectors for clinical trials." Mol Ther Methods Clin Dev 3 (2016):89-95.

   Google Scholar, Crossref, Indexed at

5. Moleirinho, Mafalda G., Sara Rosa, Manuel JT Carrondo and Ricardo JS Silva, et al. "Clinical-grade oncolytic adenovirus purification using polysorbate 20 as an alternative for cell lysis." Curr Gene Ther 18 (2018): 366-374.

   Google Scholar, Crossref, Indexed at

6. James, Kevin T., Brad Cooney, Kate Agopsowicz and Mary Ann Trevors, et al "Novel high-throughput approach for purification of infectious virions." Sci Rep 6 (2016): 36826.

   Google Scholar, Crossref, Indexed at